Quest PharmaTech Inc News

Quest PharmaTech Inc: MDA EN

SEDARMay 30 04:13 · Announcements

Quest PharmaTech Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN

SEDARMay 30 04:07 · Announcements

Quest PharmaTech Inc: INTERIM MDA AMENDED EN

SEDARMay 29 04:23 · Announcements

Quest PharmaTech Inc: INTERIM FINANCIAL STATEMENTSREPORT AMENDED EN

SEDARMay 29 04:20 · Announcements

Quest PharmaTech Inc: MDA AMENDED EN

SEDARMay 29 04:12 · Announcements

Quest PharmaTech Inc: AUDITED ANNUAL FINANCIAL STATEMENTS AMENDED EN

SEDARMay 29 03:52 · Announcements

Quest PharmaTech Brief: Says Quest Has a 42.5% Ownership Interest in OncoQuest; Adds Dividend Income Will Be Used by Quest for General Corporate Purposes

MT NewswiresJan 31 06:07

Quest PharmaTech Brief: Received a Cash Dividend Payment From OncoQuest Inc. of Approximately C$685,000

MT NewswiresJan 31 06:07

Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis

MT NewswiresJan 24 20:07

Quest PharmaTech Inc: INTERIM MDA EN

SEDARSep 22, 2023 01:16 · Announcements

Quest PharmaTech Inc: INTERIM FINANCIAL STATEMENTSREPORT EN

SEDARSep 22, 2023 01:16 · Announcements

Quest PharmaTech Provides Corporate Update

Stockhouse Sep 14, 2023 04:15

Quest PharmaTech Announces Results From AGM

Stockhouse Jul 15, 2023 04:30

Quest PharmaTech Provides Product Development Update

Stockhouse Jul 11, 2023 04:30